Showing results (11-20 of 15) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Leukemia|February 5, 2025
Phase 1 clinical trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myelomaGayathri Ravi, Shambavi Richard, Shaji Kumar, et al.Nature Medicine|February 14, 2017
The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemiaNina Fenouille, Christopher F Bassil, Issam Ben-Sahra, et al.Blood|June 3, 2026
Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myelomaSusan Bal, Myo Htut, Omar Nadeem, et al.Leukemia|January 7, 2026
Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human studyNoffar Bar, Thomas Martin, Craig C Hofmeister, et al.Cell|February 21, 2017
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in CancerMichael R Burgess, Eugene Hwang, Rana Mroue, et al.Pageof 2